IPSEN, OOO

🇷🇺Russia

Country: 🇷🇺Russia

Ownership: -

Established: 1929-01-01

Employees: 5.7K

Market Cap: $9.8B

Website: https://www.ipsen.com/

Clinical Trials

Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children

Phase 3

Completed

Conditions: Upper Limb Spasticity (Altered Skeletal Muscle Performance) in Children

Interventions: Biological: Botulinum toxin type A

First Posted Date: 2014-04-08

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 212

Registration Number: NCT02106351

Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients

Phase 4

Completed

Conditions: NeuroEndocrine Tumours

Interventions: Drug: lanreotide acetate

First Posted Date: 2014-03-03

Last Posted Date: 2019-06-07

Lead Sponsor: Ipsen

Target Recruit Count: 50

Registration Number: NCT02075606

Locations: 🇬🇧
King's College Hospital, London, United Kingdom
🇬🇧
Queen Elizabeth Hospital, Birmingham, United Kingdom
🇬🇧
Maidstone Hospital, Maidstone, United Kingdom

and more 11 locations

Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer

Phase 3

Terminated

Conditions: Prostatic Neoplasms, Castration-Resistant

Interventions: Drug: Placebo
Drug: Tasquinimod

First Posted Date: 2014-02-07

Last Posted Date: 2021-04-23

Lead Sponsor: Ipsen

Target Recruit Count: 146

Registration Number: NCT02057666

Locations: 🇨🇳
Beijing Chao-Yang Hospital Capital Medical University, Beijing, Beijing, China
🇨🇳
Beijing Hospital of Ministry of Health, Beijing, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, Beijing, China

and more 33 locations

RELIEF Study: Lower Limb Pain Relief After Injection Cycles in Adults Suffering From Lower Limb Spasticity Following Stroke

Completed

Conditions: Lower Limb Spasticity

Interventions: Biological: Botulinum toxin type A

First Posted Date: 2013-12-25

Last Posted Date: 2019-07-29

Lead Sponsor: Ipsen

Target Recruit Count: 186

Registration Number: NCT02020980

Locations: 🇪🇸
Hospital Marítimo Oza, A Coruña, Spain
🇪🇸
Hospital de Cruces, Bilbao, Spain
🇪🇸
Hospital Dr Negrín, Las Palmas De G.C., Spain

and more 25 locations

Programme of Acromegaly Screening in Patients With Associated Somatic Disorders

Completed

Conditions: Acromegaly

Interventions: Other: Non-interventional cross-sectional survey

First Posted Date: 2013-12-25

Last Posted Date: 2021-05-26

Lead Sponsor: Ipsen

Target Recruit Count: 367

Registration Number: NCT02020967

Locations: 🇷🇺
Endocrinology Hospital at First Moscow State Medical University, Moscow, Russian Federation
🇷🇺
Moscow Board of Health Endocrinology Dispensary, Moscow, Russian Federation

Predictive Factors Study

Terminated

Conditions: Acromegaly

Interventions: Drug: Somatuline Autogel® (lanreotide) 60, 90, 120 mg.

First Posted Date: 2013-12-25

Last Posted Date: 2019-01-14

Lead Sponsor: Ipsen

Target Recruit Count: 5

Registration Number: NCT02020499

Locations: 🇦🇺
Royal North Shore Hospital, St Leonards, New South Wales, Australia
🇦🇺
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
🇦🇺
Royal Brisbane & Women's Hospital, Herston, Queensland, Australia

and more 2 locations

Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice

Completed

Conditions: Photodynamic Transurethral Resection of the Bladder (TUR-B)

Interventions: Drug: Hexvix

First Posted Date: 2013-12-16

Last Posted Date: 2019-08-16

Lead Sponsor: Ipsen

Target Recruit Count: 400

Registration Number: NCT02012036

Locations: 🇩🇪
Caritas-Krankenhaus St. Josef, Klinik fuer Urologie, Regensburg, Germany
🇩🇪
Klinikverbund Südwest, Sindelfingen, Germany

Description of Sign-and-symptom Associations at Acromegaly Diagnosis.

Completed

Conditions: Acromegaly

First Posted Date: 2013-12-16

Last Posted Date: 2019-08-05

Lead Sponsor: Ipsen

Target Recruit Count: 648

Registration Number: NCT02012127

Locations: 🇫🇷
Hôpital de la Timone, Marseille, France
🇫🇷
Hôpitaux de Brabois, Nancy, France
🇫🇷
CHR Orléans - Hôpital la Source, Orléans, France

and more 22 locations

A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months

Completed

Conditions: Deep Infiltrating Endometriosis (DIE)

Interventions: Drug: Triptorelin Acetate 3.75mg intramuscular injection

First Posted Date: 2013-09-16

Last Posted Date: 2018-12-06

Lead Sponsor: Ipsen

Target Recruit Count: 402

Registration Number: NCT01942369

Locations: 🇨🇳
Chinese PLA General Hospital, Beijing, China
🇨🇳
Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
🇨🇳
Shenzhen People's Hospital, Shenzhen, China

and more 15 locations

Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm]

Completed

Conditions: Cervical Dystonia

First Posted Date: 2013-04-25

Last Posted Date: 2019-01-14

Lead Sponsor: Ipsen

Target Recruit Count: 372

Registration Number: NCT01840462

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy